| Symbol |
Name |
|
ARG1
|
arginase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
CD274
|
CD274 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD80
|
CD80 molecule
|
|
CD86
|
CD86 molecule
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
DLG5
|
discs, large homolog 5 (Drosophila)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FOXP3
|
forkhead box P3
|
|
GLMN
|
glomulin, FKBP associated protein
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
IL10
|
interleukin 10
|
|
IL4I1
|
interleukin 4 induced 1
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LILRB4
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4
|
|
LST1
|
leukocyte specific transcript 1
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G2D
|
phospholipase A2, group IID
|
|
PLA2G2E
|
phospholipase A2, group IIE
|
|
PLA2G2F
|
phospholipase A2, group IIF
|
|
PLA2G5
|
phospholipase A2, group V
|
|
RC3H1
|
ring finger and CCCH-type domains 1
|
|
SDC4
|
syndecan 4
|
|
SFTPD
|
surfactant protein D
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SPN
|
sialophorin
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
VSIG4
|
V-set and immunoglobulin domain containing 4
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
